A Peninsula biotech company focusing on a deadly lung-scarring disease lost more than half its stock value Monday after ...

Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 trial of its lead drug for idiopathic pulmonary fibrosis (IPF) after seeing a ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

Many people at risk for lung cancer including current and former smokers undergo regular screening for lung cancer with a low ...

More than 2,500 patients are currently waiting for that lifesaving transplant in Michigan. More than 100,000 are waiting nationwide. The best way to save lives is by joining the Donor Registry. You ...

The FDA has granted priority review to brensocatib to treat patients with non-cystic fibrosis bronchiectasis, according to a ...

What makes cancer the deadliest depends upon how many people have it and what percentage of those people actually survive.

FLASH radiation therapy could one day cure complex tumors and cancers while limiting the toll of radiation on the body. France's Institut Curie hopes to install one of the special machines in its ...

lung cancer was the fifth largest leading cause of cancer deaths worldwide. Those cases were nearly exclusively the subtype adenocarcinoma - a tumour that forms in the glandular tissue - and ...